PEDMARK Trademark

Trademark Overview

On Wednesday, January 18, 2017, a trademark application was filed for PEDMARK with the United States Patent and Trademark Office. The USPTO has given the PEDMARK trademark a serial number of 87305680. The federal status of this trademark filing is REGISTERED as of Tuesday, September 29, 2020. This trademark is owned by Fennec Pharmaceuticals, Inc.. The PEDMARK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, sodium thiosulfate used for the prevention of ototoxicity from cisplatin in pediatric patients
pedmark

General Information

Serial Number87305680
Word MarkPEDMARK
Filing DateWednesday, January 18, 2017
Status700 - REGISTERED
Status DateTuesday, September 29, 2020
Registration Number6164350
Registration DateTuesday, September 29, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, sodium thiosulfate used for the prevention of ototoxicity from cisplatin in pediatric patients

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 25, 2017
Primary Code005
First Use Anywhere DateWednesday, July 22, 2020
First Use In Commerce DateWednesday, July 22, 2020

Trademark Owner History

Party NameFennec Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709
Party NameFennec Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709
Party NameFennec Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709

Trademark Events

Event DateEvent Description
Tuesday, September 29, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, August 22, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, August 21, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 30, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, July 24, 2020USE AMENDMENT FILED
Friday, July 24, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, January 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 27, 2020EXTENSION 5 GRANTED
Wednesday, January 22, 2020EXTENSION 5 FILED
Monday, January 27, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 22, 2020TEAS EXTENSION RECEIVED
Saturday, July 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 25, 2019EXTENSION 4 GRANTED
Thursday, July 25, 2019EXTENSION 4 FILED
Thursday, July 25, 2019TEAS EXTENSION RECEIVED
Saturday, January 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 17, 2019EXTENSION 3 GRANTED
Thursday, January 17, 2019EXTENSION 3 FILED
Thursday, January 17, 2019TEAS EXTENSION RECEIVED
Wednesday, July 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 23, 2018EXTENSION 2 GRANTED
Monday, July 23, 2018EXTENSION 2 FILED
Monday, July 23, 2018TEAS EXTENSION RECEIVED
Thursday, January 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 16, 2018EXTENSION 1 GRANTED
Tuesday, January 16, 2018EXTENSION 1 FILED
Tuesday, January 16, 2018TEAS EXTENSION RECEIVED
Tuesday, July 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 30, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 13, 2017ASSIGNED TO EXAMINER
Wednesday, January 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 21, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

pedmark from ototoxicity cisplatin pediatric patients prevention used preparations namely sodium